Opexa Therapeutics (OPXA) Enters Merger Deal with Acer Therapeutics
Opexa Therapeutics, Inc. (Nasdaq: OPXA) is gaining 56% in pre-open trade after the company and Acer Therapeutics Inc. entered into ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
